Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples